Sang-Won Lee and Jaewoo Kang to share early insights from Seer's 20,000-sample collaboration with Korea University in breakfast symposium on AI-driven multi-cancer screening.
Trainers from five stables were fined thousands of dollars for breaching prohibited substance rules. New research might yet ...
The deadline for ACRL 2027 contributed paper, panel session, and workshop proposals is coming up June 5, 2026. The ACRL 2027 Conference to be held April 7-10, 2027, in Portland, Oregon, and online, ...
From heads of state to those jittery first-timers on open mic nights, most speakers of any stripe will admit that holding an ...
Tooth whitening remains one of the most sought-after interventions in aesthetic dentistry and continues to attract strong interest from clinicians, ...
On April 30, the Brandeis Undergraduate Research and Creative Collaborations hosted its spring research symposium. This ...
Monopar Therapeutics Inc. (“Monopar” or the “Company”) (Nasdaq: MNPR), a clinical‐stage biopharmaceutical company developing innovative treatments for patients with unmet medical needs, today ...
NDA submission follows agreement with FDA on confirmatory trial, a requirement of the accelerated approval pathwayConfirmatory trial designed to ...
Seeking mental health help is a significant step, but that first intake session can often feel more like paperwork than progress, and a significant proportion of people 'drop out' or never return for ...
A growing number of U.S. college instructors are turning to oral exams to help combat an AI crisis in higher education ...
Immatics is committed to making a meaningful impact on the lives of patients with cancer. We are the global leader in precision targeting of PRAME, a target expressed in more than 50 cancers. Our ...
LEXINGTON, Mass.--(BUSINESS WIRE)--TRIANA Biomedicines, Inc. (TRIANA), a leading biopharmaceutical company focused on advancing a target-first and proximity-first molecular glue discovery platform to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results